标题
A Multi-Dimensional Comparison of Alzheimer’s Disease Neurodegenerative Biomarkers
作者
关键词
-
出版物
JOURNAL OF ALZHEIMERS DISEASE
Volume 87, Issue 1, Pages 197-209
出版商
IOS Press
发表日期
2022-03-09
DOI
10.3233/jad-215724
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
- (2021) Yu Guo et al. Alzheimers Research & Therapy
- Alzheimer’s disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline
- (2021) Marco Bucci et al. MOLECULAR PSYCHIATRY
- The implications of different approaches to define AT(N) in Alzheimer disease
- (2020) Niklas Mattsson-Carlgren et al. NEUROLOGY
- The prognostic value of ATN Alzheimer biomarker profiles in cognitively normal individuals
- (2019) Stephanie J.B. Vos et al. NEUROLOGY
- ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes
- (2019) Anja Soldan et al. NEUROLOGY
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
- (2019) Niklas Mattsson et al. JAMA Neurology
- Predicting long‐term clinical stability in amyloid‐positive subjects by FDG ‐ PET
- (2019) Leonardo Iaccarino et al. Annals of Clinical and Translational Neurology
- FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study
- (2019) Ya-Nan Ou et al. Alzheimers Research & Therapy
- Frequency and longitudinal clinical outcomes of Alzheimer's AT(N) biomarker profiles: A longitudinal study
- (2019) Jin-Tai Yu et al. Alzheimers & Dementia
- Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin
- (2019) Michelle M. Mielke et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- The National Institute on Aging—Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials
- (2018) Jeffrey Cummings Alzheimers & Dementia
- A Genome-Wide Association Study of α-Synuclein Levels in Cerebrospinal Fluid
- (2018) Xiao-ling Zhong et al. NEUROTOXICITY RESEARCH
- FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort
- (2018) Silvia Paola Caminiti et al. NeuroImage-Clinical
- Current state of Alzheimer’s fluid biomarkers
- (2018) José Luis Molinuevo et al. ACTA NEUROPATHOLOGICA
- Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment
- (2018) Silke Kern et al. JAMA Neurology
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
- (2016) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- PGRN Is Associated with Late-Onset Alzheimer’s Disease: a Case–Control Replication Study and Meta-analysis
- (2016) Hui-Min Xu et al. MOLECULAR NEUROBIOLOGY
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
- (2016) Jonathan D. Rohrer et al. NEUROLOGY
- Neuroimaging of hippocampal atrophy in early recognition of Alzheimer´s disease – a critical appraisal after two decades of research
- (2016) Johannes Schröder et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease
- (2015) Hlin Kvartsberg et al. Alzheimers & Dementia
- The Role of PGRN in Alzheimer’s Disease
- (2015) Hua Jing et al. MOLECULAR NEUROBIOLOGY
- Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer’s Disease and Mild Cognitive Impairment: MRI and18F-FDG PET Quantitative Analysis Using FreeSurfer
- (2015) Matthieu Bailly et al. Biomed Research International
- Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models
- (2014) S Sakura Minami et al. NATURE MEDICINE
- TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
- (2014) G. Kleinberger et al. Science Translational Medicine
- Amyloid deposition, hypometabolism, and longitudinal cognitive decline
- (2012) Susan M. Landau et al. ANNALS OF NEUROLOGY
- Posterior Cingulate Glucose Metabolism, Hippocampal Glucose Metabolism, and Hippocampal Volume in Cognitively Normal, Late-Middle-Aged Persons at 3 Levels of Genetic Risk for Alzheimer Disease
- (2012) Hillary D. Protas et al. JAMA Neurology
- Visinin-like protein-1: Diagnostic and prognostic biomarker in Alzheimer disease
- (2011) Rawan Tarawneh et al. ANNALS OF NEUROLOGY
- Rescue of Progranulin Deficiency Associated with Frontotemporal Lobar Degeneration by Alkalizing Reagents and Inhibition of Vacuolar ATPase
- (2011) A. Capell et al. JOURNAL OF NEUROSCIENCE
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
- (2010) Rebecca Craig-Schapiro et al. BIOLOGICAL PSYCHIATRY
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
- (2010) Zhen Hong et al. BRAIN
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers
- (2009) N. Schuff et al. BRAIN
- Fluorodeoxyglucose–Positron-Emission Tomography, Single-Photon Emission Tomography, and Structural MR Imaging for Prediction of Rapid Conversion to Alzheimer Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis
- (2008) Y. Yuan et al. AMERICAN JOURNAL OF NEURORADIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started